Meta Pixel

News and Announcements

Paul Rayson is appointed as an Advisor and Investment Committee member of the WI Capital team

  • Published August 20, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Wholesale Investor Appoints Paul Rayson as Advisor / Investment Committee for WI Capital

Wholesale Investor is pleased to announce that Paul Rayson has been appointed to the WI Capital team as an Advisor and Investment Committee member.

Paul has worked in the financial services industry for over 20 years and has extensive experience in investment markets, technology, banking, risk management and insurance. Paul is currently the Chief Executive Officer of Hearts and Minds Investments Ltd, an ASX listed investment company. Paul is the former Managing Director of Commonwealth Securities Ltd (CommSec) and Australian Investment Exchange Ltd (Ausiex) and prior to that the Managing Director of Colonial Mutual Life Assurance Society Ltd. Paul has also held senior CFO and governance roles across large financial services businesses. Prior to financial servic

es, Paul held senior roles in Consulting and Chartered Accounting firms specialising in corporate advisory and strategy.

Paul holds a commerce degree and is a Fellow of the Institute of Chartered Accountants and a member of the Australian Institute of Company Directors.

“With Paul’s leadership in the Capital Markets and Funds Management, we are very excited to work with Paul as we build the WI Capital business and create a new layer of opportunity for the ecosystem.” – Steve Torso.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now